OrbusNeich Medical Group Limited ("OrbusNeich"), a global leader in vascular intervention devices, recently announced it successfully raised $200 million, led by Shenzhen Capital Group, with participation from CCB International, Star River Capital, Wanhui Capital, and CMS.

CEC Capital and CITIC Securities served as the financial advisors in this transaction for OrbusNeich.

This financing will accelerate the continuous development of new products and promote the further expansion of its business in Greater China and worldwide. Headquartered in Hong Kong, OrbusNeich is an international medical device innovation company in the field of vascular intervention. It has manufacturing and research and development bases in China, the Netherlands, and the United States, with subsidiaries worldwide.